MacNeil; Douglas J.
Patent Applications and Registrations
Patent applications and USPTO patent grants for MacNeil; Douglas J..The latest application filed is for "peptide compounds for treating obesity and insulin resistance".
- MacNeil; Douglas J. - Westfield NJ
- MacNeil, Douglas J - Westfield NJ
| Patent | Date |
|---|---|
| Peptide compounds for treating obesity and insulin resistance App 20090104210 - Tota; Michael R. ; et al. | 2009-04-23 |
| Combination Therapy for the Treatment of Obesity App 20080064632 - Amatruda; John M. ; et al. | 2008-03-13 |
| Combination therapy for the treatment of diabetes App 20070099884 - Erondu; Ngozi E. ; et al. | 2007-05-03 |
| Combination therapy for the treatment of obesity App 20060270650 - MacNeil; Tanya ; et al. | 2006-11-30 |
| Combination therapy for the treatment of hypertension App 20060160834 - Fong; Tung M. ; et al. | 2006-07-20 |
| DNA molecules encoding the melanocortin 4 receptor protein from rhesus monkey Grant 7,029,865 - MacNeil , et al. April 18, 2 | 2006-04-18 |
| Combination therapy for the treatment of obesity App 20050288213 - MacNeil, Douglas J. ; et al. | 2005-12-29 |
| Method for treating circadian rhythm disruptions App 20050107411 - MacNeil, Douglas J ; et al. | 2005-05-19 |
| Combination therapy for the treatment of obesity App 20040122033 - Nargund, Ravi P. ; et al. | 2004-06-24 |
| Spiro-indolines as Y5 receptor antagonists App 20040063942 - Gao, Ying-Duo ; et al. | 2004-04-01 |
| DNA molecules encoding splice variants of the human melanocortin 1 receptor protein Grant 6,693,184 - Howard , et al. February 17, 2 | 2004-02-17 |
| Spiro-indolines as Y5 receptor antagonists Grant 6,638,942 - Gao , et al. October 28, 2 | 2003-10-28 |
| DNA molecules encoding the melanocortin 4 receptor protein from rhesus monkey App 20030166009 - MacNeil, Douglas J. ; et al. | 2003-09-04 |
| Spiro-indolines as Y5 receptor antagonists App 20020058813 - Gao, Ying-Duo ; et al. | 2002-05-16 |
| Spiro-indolines as Y5 receptor antagonists Grant 6,313,298 - Gao , et al. November 6, 2 | 2001-11-06 |
| Spiro-indolines as Y5 receptor antagonists Grant 6,191,160 - Gao , et al. February 20, 2 | 2001-02-20 |
| Combination therapy for the treatment of diabetes and obesity Grant 5,908,830 - Smith , et al. June 1, 1 | 1999-06-01 |
| Neuropeptide Y receptor Grant 5,621,079 - Cascieri , et al. April 15, 1 | 1997-04-15 |
| Cloning genes from Streptomyces avermitilis for avermectin biosynthesis and the methods for their use Grant 5,252,474 - Gewain , et al. October 12, 1 | 1993-10-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 